License Agreements in the Biotechnology Industry

2,931 Contracts & Agreements

Browse by Company

2seventy bio, Inc. (5 contracts)
4D Molecular Therapeutics Inc (5)
89bio, Inc. (1)
ABEONA THERAPEUTICS INC. (6)
ACADIA PHARMACEUTICALS INC (7)
ACCELERON PHARMA INC (2)
Accustem Sciences Inc. (1)
Achaogen, Inc. (6)
ACHIEVE LIFE SCIENCES, INC. (3)
Acorda Therapeutics (23)
Actinium Pharmaceuticals, Inc. (4)
Acumen Pharmaceuticals, Inc. (1)
Adagio Therapeutics, Inc. (3)
Adamas Pharmaceuticals Inc (2)
Adhera Therapeutics, Inc. (15)
ADiTx Therapeutics, Inc. (1)
ADMA BIOLOGICS, INC. (2)
ADURO BIOTECH, INC. (16)
Advaxis, Inc. (5)
Adverum Biotechnologies, Inc. (12)
Aeglea BioTherapeutics, Inc. (12)
Aerovate Therapeutics, Inc. (2)
AGENUS INC (20)
AGIOS PHARMACEUTICALS INC (2)
AILERON THERAPEUTICS INC (6)
Aimmune Therapeutics, Inc. (1)
AKCEA THERAPEUTICS, INC. (2)
Akebia Therapeutics, Inc. (8)
Akouos, Inc. (1)
ALBIREO PHARMA, INC. (6)
Aldeyra Therapeutics, Inc. (3)
Alexion Pharmaceuticals (1)
Aligos Therapeutics, Inc. (4)
Alkermes plc. (10)
Allakos Inc. (6)
Allarity Therapeutics, Inc. (17)
Allena Pharmaceuticals, Inc. (2)
Alliqua BioMedical, Inc. (5)
Allogene Therapeutics, Inc. (2)
Allovir, Inc. (4)
ALNYLAM PHARMACEUTICALS, INC. (5)
Alpha Healthcare Acquisition Corp. (10)
ALPINE IMMUNE SCIENCES, INC. (6)
Altimmune, Inc. (9)
Alzamend Neuro, Inc. (6)
AMARILLO BIOSCIENCES INC (2)
AMARIN CORP PLC (4)
Amgen Inc. (2)
AMICUS THERAPEUTICS, INC. (7)
AmpliPhi Biosciences Corp (2)
Amplitude Healthcare Acquisition Corp (1)
ANAPTYSBIO INC (2)
Anika Therapeutics (3)
Anixa Biosciences Inc (7)
Annovis Bio, Inc. (3)
Apellis Pharmaceuticals, Inc. (2)
APPLIED GENETIC TECHNOLOGIES CORP (12)
Applied Therapeutics Inc. (2)
Aptevo Therapeutics Inc. (3)
Aptose Biosciences Inc. (1)
AQUINOX PHARMACEUTICALS, INC (4)
Aravive, Inc. (6)
Arbutus Biopharma Corp (7)
ARCA biopharma, Inc. (10)
Arcellx, Inc. (1)
Arcus Biosciences, Inc. (7)
Arcutis Biotherapeutics, Inc. (3)
ARDELYX, INC. (9)
ARENA PHARMACEUTICALS INC (3)
Aridis Pharmaceuticals, Inc. (5)
ARROWHEAD PHARMACEUTICALS, INC. (8)
Arsanis, Inc. (11)
Artiva Biotherapeutics, Inc. (12)
ARYA Sciences Acquisition Corp II (1)
ASSEMBLY BIOSCIENCES, INC. (4)
Atara Biotherapeutics, Inc. (14)
Athenex, Inc. (37)
ATHERSYS, INC (6)
ATOSSA GENETICS INC (7)
Atreca, Inc. (2)
Aura Biosciences, Inc. (3)
AVEO PHARMACEUTICALS INC (10)
Avid Bioservices, Inc. (6)
AVROBIO, Inc. (9)
Axovant Sciences Ltd. (4)
Ayala Pharmaceuticals, Inc. (3)
AZIYO BIOLOGICS, INC. (2)
AzurRx BioPharma, Inc. (3)
Beam Therapeutics Inc. (9)
BeiGene, Ltd. (1)
BELLICUM PHARMACEUTICALS, INC (9)
BICYCLE THERAPEUTICS Ltd (1)
BIO-PATH HOLDINGS INC (2)
bioAffinity Technologies, Inc. (2)
BioAtla, Inc. (5)
BioCardia, Inc. (1)
BIOCRYST PHARMACEUTICALS INC (4)
Biohaven Pharmaceutical Holding Co Ltd. (8)
BioLife4D Corp (4)
BIOMARIN PHARMACEUTICAL INC (8)
BioRestorative Therapies, Inc. (3)
BIOSPECIFICS TECHNOLOGIES CORP (7)
Biostage, Inc. (2)
BIOTIME INC (20)
BIOXYTRAN, INC (3)
Blue Water Vaccines Inc. (9)
bluebird bio, Inc. (22)
Blueprint Medicines Corp (1)
Bone Biologics Corp (7)
BRAINSTORM CELL THERAPEUTICS INC. (1)
BriaCell Therapeutics Corp. (1)
BridgeBio Pharma, Inc. (7)
BullFrog AI Holdings, Inc. (10)
BURZYNSKI RESEARCH INSTITUTE INC (1)
C4 Therapeutics, Inc. (3)
Cabaletta Bio, Inc. (5)
CALADRIUS BIOSCIENCES, INC. (5)
Calithera Biosciences, Inc. (1)
Calyxt, Inc. (3)
Candel Therapeutics, Inc. (6)
CAPRICOR THERAPEUTICS, INC. (13)
Capstone Therapeutics Corp. (6)
CareDx, Inc. (2)
Caribou Biosciences, Inc. (8)
CASI Pharmaceuticals, Inc. (7)
CASTLE BIOSCIENCES INC (1)
CATABASIS PHARMACEUTICALS INC (1)
CATALYST BIOSCIENCES, INC. (30)
CATALYST PHARMACEUTICALS, INC. (11)
Celcuity Inc. (2)
Cell Source, Inc. (4)
Celldex Therapeutics, Inc. (7)
Cellectar Biosciences, Inc. (1)
Cellular Biomedicine Group, Inc. (4)
Centessa Pharmaceuticals Ltd (4)
Century Therapeutics, Inc. (11)
CEREBAIN BIOTECH CORP. (1)
Chanticleer Holdings, Inc. (4)
Chardan Healthcare Acquisition 2 Corp. (1)
Chardan Healthcare Acquisition Corp. (8)
Checkmate Pharmaceuticals, Inc. (1)
Checkpoint Therapeutics, Inc. (5)
Chelsea Worldwide Inc. (1)
CHIMERIX INC (4)
Cidara Therapeutics, Inc. (3)
CLEVELAND BIOLABS INC (4)
CM Life Sciences III Inc. (2)
CohBar, Inc. (2)
Coherus BioSciences, Inc. (13)
Conatus Pharmaceuticals Inc. (6)
CONCERT PHARMACEUTICALS, INC. (2)
Consonance-HFW Acquisition Corp. (1)
CONTRAFECT Corp (2)
Corbus Pharmaceuticals Holdings, Inc. (3)
Cortexyme, Inc. (4)
Corvus Pharmaceuticals, Inc. (3)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (2)
Crinetics Pharmaceuticals, Inc. (1)
CTI BIOPHARMA CORP (4)
Cue Biopharma, Inc. (15)
Cullinan Oncology, LLC (3)
Curative Biotechnology Inc (20)
CURIS INC (2)
Cyclacel Pharmaceuticals, Inc. (7)
Cyclerion Therapeutics, Inc. (2)
CytoDyn Inc. (2)
Cytokinetics, Incorporated (1)
CytomX Therapeutics, Inc. (5)
CYTORI THERAPEUTICS, INC. (6)
CYTRX CORP (2)
Day One Biopharmaceuticals Holding Co LLC (6)
Decibel Therapeutics, Inc. (8)
Deciphera Pharmaceuticals, Inc. (1)
DelMar Pharmaceuticals, Inc. (3)
Denali Therapeutics Inc. (2)
Dermavant Sciences Ltd (10)
Dermira, Inc. (3)
Design Therapeutics, Inc. (1)
Dicerna Pharmaceuticals Inc (4)
Diffusion Pharmaceuticals Inc. (4)
Digital Development Partners, Inc. (1)
DYADIC INTERNATIONAL INC (5)
Dynamics Special Purpose Corp. (5)
DYNAVAX TECHNOLOGIES CORP (1)
Dyne Therapeutics, Inc. (1)
Eagle Pharmaceuticals, Inc. (11)
Edge Therapeutics, Inc. (2)
Editas Medicine, Inc. (8)
Eidos Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (13)
Elevation Oncology, Inc. (2)
Eliem Therapeutics, Inc. (2)
Emerald Bioscience, Inc. (10)
Emergent BioSolutions Inc. (1)
Enanta Pharmaceuticals, Inc. (1)
Enochian Biosciences Inc (2)
Entrada Therapeutics, Inc. (3)
ENZOLYTICS INC (1)
Epizyme, Inc. (2)
Erasca, Inc. (7)
Esperion Therapeutics, Inc. (1)
ESSA Pharma Inc. (2)
Evelo Biosciences, Inc. (6)
EXACT SCIENCES CORP (15)
Exelixis (5)
EXICURE, INC. (13)
FATE THERAPEUTICS INC (18)
FENNEC PHARMACEUTICALS INC. (2)
Fibrocell Science, Inc. (3)
FIBROGEN INC (11)
Finch Therapeutics Group, Inc. (4)
FIVE PRIME THERAPEUTICS INC (12)
Flex Pharma, Inc. (7)
Flexion Therapeutics Inc (2)
FLUOROPHARMA MEDICAL, INC. (2)
Forma Therapeutics Holdings, Inc., (2)
Fortress Biotech, Inc. (1)
Frequency Therapeutics, Inc. (3)
FS Development Corp. (5)
Fusion Pharmaceuticals Inc. (3)
G1 Therapeutics, Inc. (2)
GALECTIN THERAPEUTICS INC (1)
Gemphire Therapeutics Inc. (3)
Gene Biotherapeutics, Inc. (11)
GENELUX CORP (4)
Generation Bio Co. (4)
GENOCEA BIOSCIENCES, INC. (2)
Genprex, Inc. (11)
GeoVax Labs, Inc. (5)
GERON CORP (6)
Gilead Sciences (11)
Global Blood Therapeutics, Inc. (2)
GLYCOMIMETICS INC (2)
GOLDENWELL BIOTECH, INC. (2)
Gossamer Bio, Inc. (3)
Grail, Inc. (5)
Graphite Bio, Inc. (7)
Greater Cannabis Company, Inc. (1)
Greenwich LifeSciences, Inc. (3)
Gritstone Oncology, Inc. (5)
GT Biopharma, Inc. (18)
GTX INC (24)
HARBOR DIVERSIFIED, INC. (4)
Harpoon Therapeutics, Inc. (3)
HCW Biologics Inc. (1)
Health Sciences Acquisitions Corp (2)
HEAT BIOLOGICS, INC. (32)
HedgePath Pharmaceuticals, Inc. (5)
HilleVax, Inc. (1)
Hillstream BioPharma Inc. (3)
HISTOGENICS CORP (17)
Homology Medicines, Inc. (13)
HOOKIPA Pharma Inc. (2)
HUMANIGEN, INC (1)
iBio, Inc. (5)
Icosavax, Inc. (8)
IDEAYA Biosciences, Inc. (5)
IDERA PHARMACEUTICALS, INC. (5)
Immix Biopharma, Inc. (2)
IMMUCELL CORP (2)
IMMUNE PHARMACEUTICALS INC (7)
Immune Therapeutics, Inc. (8)
ImmunoCellular Therapeutics, Ltd. (11)
IMMUNOGEN INC (14)
Immunome Inc. (6)
IMMUNOMEDICS INC (3)
IN8BIO, INC. (8)
Incyte (4)
INFINITY PHARMACEUTICALS, INC. (5)
Inhibikase Therapeutics, Inc. (1)
Inhibrx, Inc. (7)
Inmune Bio, Inc. (9)
Innovation Pharmaceuticals Inc. (1)
INOVIO PHARMACEUTICALS, INC. (3)
Inozyme Pharma, Inc. (1)
INSMED Inc (6)
Intellia Therapeutics, Inc. (12)
INTERCEPT PHARMACEUTICALS, INC. (9)
International Stem Cell CORP (9)
INTREXON CORP (1)
Intrinsic Medicine, Inc. (7)
IONIS PHARMACEUTICALS INC (22)
IOVANCE BIOTHERAPEUTICS, INC. (3)
IRONWOOD PHARMACEUTICALS INC (9)
Isoray, Inc. (12)
Janux Therapeutics, Inc. (1)
Jounce Therapeutics, Inc. (2)
Kadmon Holdings, Inc. (2)
KalVista Pharmaceuticals, Inc. (1)
Karuna Therapeutics, Inc. (3)
Karyopharm Therapeutics Inc. (4)
Keros Therapeutics, Inc. (3)
Kezar Life Sciences, Inc. (2)
Kiniksa Pharmaceuticals, Ltd. (4)
Kiromic Biopharma, Inc. (4)
Kura Oncology, Inc. (9)
LA JOLLA PHARMACEUTICAL CO (2)
Lantern Pharma Inc. (6)
LEAP THERAPEUTICS, INC. (3)
LEXICON PHARMACEUTICALS, INC. (1)
LianBio (19)
LifeSci Acquisition Corp. (1)
Ligand Pharmaceuticals Incorporated (23)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (2)
Locust Walk Acquisition Corp. (1)
LogicBio Therapeutics, Inc. (5)
LONGEVERON LLC (5)
Lyell Immunopharma, Inc. (1)
MACROGENICS INC (4)
MADRIGAL PHARMACEUTICALS, INC. (2)
Magenta Therapeutics, Inc. (6)
MAIA Biotechnology, Inc. (6)
MANHATTAN SCIENTIFICS INC (1)
Marker Therapeutics, Inc. (2)
MATEON THERAPEUTICS INC (8)
Matinas BioPharma Holdings, Inc. (1)
MEDICINOVA INC (8)
MEI Pharma, Inc. (6)
MeiraGTx Holdings plc (9)
MERRIMACK PHARMACEUTICALS INC (1)
Mersana Therapeutics, Inc. (7)
Merus N.V. (1)
Metacrine, Inc. (1)
Millendo Therapeutics, Inc. (11)
MiMedx Group, Inc. (10)
Minerva Neurosciences, Inc. (8)
MiNK Therapeutics, Inc. (1)
MIRAGEN THERAPEUTICS, INC. (14)
Mirum Pharmaceuticals, Inc. (7)
Molecular Templates, Inc. (6)
Moleculin Biotech, Inc. (13)
Momenta Pharmaceuticals, Inc. (2)
Monopar Therapeutics (11)
Monte Rosa Therapeutics, Inc. (1)
Morphic Holding, Inc. (2)
MUSTANG BIO, INC. (6)
Myovant Sciences Ltd. (2)
Myriad Genetics, Inc. (2)
NANOVIRICIDES, INC. (4)
NantKwest, Inc. (12)
Natera, Inc. (1)
NAVIDEA BIOPHARMACEUTICALS, INC. (4)
NEUROBIOLOGICAL TECHNOLOGIES INC (5)
NEUROCRINE BIOSCIENCES INC (2)
NEUROTROPE BIOSCIENCE, INC. (3)
Neurotrope, Inc. (1)
NEWLINK GENETICS CORP (45)
NexImmune, Inc. (1)
NextCure, Inc. (2)
Nkarta, Inc. (1)
NOVAVAX INC (8)
Novus Therapeutics, Inc. (3)
NTN BUZZTIME INC (6)
Nuo Therapeutics, Inc. (7)
Nuvectis Pharma, Inc. (4)
Ohr Pharmaceutical Inc (2)
Omega Therapeutics, Inc. (5)
OncoCyte Corp (4)
Oncorus, Inc. (7)
ONCOSEC MEDICAL Inc (1)
Ophthotech Corp. (7)
Opko Health, Inc. (12)
ORAGENICS INC (10)
Orchard Therapeutics plc (1)
Organogenesis Holdings Inc. (1)
ORGANOVO HOLDINGS, INC. (5)
Oric Pharmaceuticals, Inc. (1)
Outlook Therapeutics, Inc. (3)
Ovid Therapeutics Inc. (4)
Oyster Point Pharma, Inc. (1)
PALATIN TECHNOLOGIES INC (2)
Passage BIO, Inc. (3)
PepGen Inc. (2)
Pfenex Inc. (13)
PharmaCyte Biotech, Inc. (3)
PhaseBio Pharmaceuticals Inc (7)
PIERIS PHARMACEUTICALS, INC. (7)
PLURISTEM THERAPEUTICS INC (3)
POLARITYTE, INC. (3)
PORTOLA PHARMACEUTICALS INC (1)
Poseida Therapeutics, Inc. (10)
Praxis Precision Medicines, Inc. (2)
PRECISION BIOSCIENCES INC (9)
Prelude Therapeutics Inc (2)
PREMIER BIOMEDICAL INC (6)
Prevail Therapeutics Inc. (2)
Principia Biopharma Inc. (5)
Progenics Pharmaceuticals, Inc. (9)
Prometheus Biosciences, Inc. (5)
Protagenic Therapeutics, Inc. (3)
Protagonist Therapeutics, Inc (1)
Protalix BioTherapeutics, Inc. (7)
PROTEON THERAPEUTICS INC (3)
PROTEOSTASIS THERAPEUTICS, INC. (10)
Prothena Corp plc (14)
PTC THERAPEUTICS, INC. (5)
PUMA BIOTECHNOLOGY, INC. (14)
Pyxis Oncology, Inc. (7)
Q BioMed Inc. (3)
Qrons Inc. (5)
Radius Health, Inc. (5)
Rallybio Corp (4)
RAPT Therapeutics, Inc. (1)
RECURSION PHARMACEUTICALS, INC. (3)
Regeneron Pharmaceuticals (11)
REGENERX BIOPHARMACEUTICALS INC (3)
REGENXBIO Inc. (33)
Regulus Therapeutics Inc. (2)
Reneo Pharmaceuticals, Inc. (1)
Repare Therapeutics Inc. (1)
Retrophin, Inc. (2)
REXAHN PHARMACEUTICALS, INC. (5)
Rezolute, Inc. (6)
RHYTHM PHARMACEUTICALS, INC. (6)
RIGEL PHARMACEUTICALS INC (3)
RITTER PHARMACEUTICALS INC (13)
ROCKET PHARMACEUTICALS, INC. (1)
Rubius Therapeutics, Inc. (1)
Sage Therapeutics, Inc. (6)
Sana Biotechnology, Inc. (40)
SANGAMO THERAPEUTICS, INC (15)
Sarepta Therapeutics, Inc. (7)
Savara Inc (5)
SEATTLE GENETICS INC (9)
SELECTA BIOSCIENCES INC (9)
SELLAS Life Sciences Group, Inc. (37)
Sensei Biotherapeutics, Inc. (1)
Seres Therapeutics, Inc. (2)
Sesen Bio, Inc. (6)
Shattuck Labs, Inc. (1)
Shuttle Pharmaceuticals Holdings, Inc. (1)
Sierra Oncology, Inc. (5)
Sigilon Therapeutics, Inc. (7)
Silverback Therapeutics, Inc. (4)
Social Capital Suvretta Holdings Corp. III (1)
SOLENO THERAPEUTICS INC (1)
Solid Biosciences Inc. (18)
SOLIGENIX, INC. (2)
SOPHIRIS BIO INC. (4)
Sorrento Therapeutics, Inc. (13)
Spectrum Pharmaceuticals, Inc. (11)
Spero Therapeutics, Inc. (11)
SPHERIX INC (5)
Spring Bank Pharmaceuticals, Inc. (1)
SpringWorks Therapeutics, Inc. (2)
SPRUCE BIOSCIENCES, INC. (1)
SQZ Biotechnologies Co (2)
Stellar Biotechnologies, Inc. (9)
Stoke Therapeutics, Inc. (4)
Sun BioPharma, Inc. (4)
SUNESIS PHARMACEUTICALS INC (5)
Sunshine Biopharma, Inc (2)
Surface Oncology, Inc. (3)
SUTRO BIOPHARMA, INC. (5)
Syndax Pharmaceuticals Inc (15)
SYNLOGIC, INC. (16)
Synthetic Biologics, Inc. (10)
Syros Pharmaceuticals, Inc. (2)
T2 Biosystems, Inc. (1)
Talaris Therapeutics, Inc. (3)
Taysha Gene Therapies, Inc. (3)
TENAX THERAPEUTICS, INC. (9)
Tenaya Therapeutics, Inc. (1)
TG THERAPEUTICS, INC. (4)
Therapeutics Acquisition Corp. (2)
Tocagen Inc (4)
Tonix Pharmaceuticals Holding Corp. (6)
Tracon Pharmaceuticals, Inc. (8)
Transcode Therapeutics, Inc. (2)
Translate Bio, Inc. (2)
TREVENA INC (1)
Trovagene, Inc. (2)
TScan Therapeutics, Inc. (3)
Turning Point Therapeutics, Inc. (3)
U.S. Stem Cell, Inc. (2)
Ultragenyx Pharmaceutical Inc. (18)
Unicycive Therapeutics, Inc. (3)
uniQure N.V. (5)
United Therapeutics Corp (4)
Unity Biotechnology, Inc. (29)
Unum Therapeutics Inc. (1)
UroGen Pharma Ltd. (2)
VACCINEX, INC. (2)
Vaccitech plc (4)
Vanda Pharmaceuticals Inc. (11)
Vaxart, Inc. (1)
Vaxcyte, Inc. (2)
Vaxxinity, Inc. (1)
VBI Vaccines Inc (1)
Vera Therapeutics, Inc. (4)
Verastem, Inc. (3)
Vericel Corp (6)
Vertex Pharmaceuticals Inc (2)
Verve Therapeutics, Inc. (3)
VICAL INC (20)
Vicapsys Life Sciences, Inc. (2)
Viela Bio, Inc. (2)
Vigil Neuroscience, Inc. (1)
Viking Therapeutics, Inc. (6)
Vir Biotechnology, Inc. (15)
Virios Therapeutics, LLC (1)
VistaGen Therapeutics, Inc. (8)
VITAL THERAPIES INC (1)
Vor Biopharma Inc. (4)
Voyager Therapeutics, Inc. (7)
vTv Therapeutics Inc. (10)
Werewolf Therapeutics, Inc. (1)
WINDTREE THERAPEUTICS INC (8)
XBiotech Inc. (1)
Xencor Inc (9)
Xenetic Biosciences, Inc. (7)
Xenon Pharmaceuticals Inc. (5)
Xilio Therapeutics, Inc. (3)
XOMA Corp (18)
Y-mAbs Therapeutics, Inc. (6)
YIELD10 BIOSCIENCE, INC. (1)
Yulong Eco-Materials Ltd (2)
ZAFGEN, INC. (8)
Zai Lab Ltd (5)
Zentalis Pharmaceuticals, LLC (4)
ZIOPHARM ONCOLOGY INC (9)

Recent Contracts

LICENSE AGREEMENT by and between Shanghai Jemincare Pharmaceutical Co., Ltd. and RAPT Therapeutics, Inc. dated as of December 22, 2024 (RAPT Therapeutics, Inc., Filed With SEC on December 23, 2024)
Amendment #1 to License Agreement by and between the Company and Akebia Therapeutics, Inc. dated December 13, 2024 (Cyclerion Therapeutics, Inc., Filed With SEC on December 17, 2024)
Amendment to License Agreement between the BC Cancer Agency, UBC and the Company, dated May 25, 2021 (Schedules have been omitted pursuant to Item 601(b)(10) of Regulation S-K.... (ESSA Pharma Inc., Filed With SEC on December 17, 2024)
License Agreement, dated as of April 8, 2021, by and between Kalaris Therapeutics, Inc. (formerly Theia Therapeutics, Inc.) and the Regents of the University of California, as... (Allovir, Inc., Filed With SEC on December 9, 2024)
Cell Line License Agreement, effective October 22, 2024, by and between WuXi Biologics Ireland Limited and Jade Biosciences, Inc (Aerovate Therapeutics, Inc., Filed With SEC on December 3, 2024)
APRIL License Agreement, dated October 30, 2024, by and between Paragon Therapeutics, Inc. and Jade Biosciences, Inc (Aerovate Therapeutics, Inc., Filed With SEC on December 3, 2024)
Nonexclusive License Agreement between Neurogene Inc. and the Board of Trustees of the Leland Stanford Junior University dated August 6, 2024 (AQUINOX PHARMACEUTICALS, INC, Filed With SEC on November 18, 2024)
Storage License Agreement by and among the Company, BKPBIOTECH, Inc. and JLSA2 Therapeutics, Inc., dated as of September 23, 2024 (Dynamics Special Purpose Corp., Filed With SEC on November 14, 2024)
Amendment 4 to Exclusive License Agreement, dated October 28, 2024, by and between the Registrant and GlaxoSmithKline Intellectual Property (No. 3) Limited (Spero Therapeutics, Inc., Filed With SEC on November 14, 2024)
Exclusive License Agreement (PBML04), dated July 31, 2024, by and between the Registrant and Gemma Biotherapeutics, Inc (Passage BIO, Inc., Filed With SEC on November 13, 2024)
Exclusive License Agreement (PBKR03), dated July 31, 2024, by and between the Registrant and Gemma Biotherapeutics, Inc (Passage BIO, Inc., Filed With SEC on November 13, 2024)
Exclusive License Agreement (PBGM01), dated July 31, 2024, by and between the Registrant and Gemma Biotherapeutics, Inc (Passage BIO, Inc., Filed With SEC on November 13, 2024)
Amendment No. 2 to License Agreement, dated August 7, 2024, by and between Immunome, Inc. and Bristol-Myers Squibb Company (Immunome Inc., Filed With SEC on November 13, 2024)
First Amendment to Option and License Agreement, by and between Registrant and AstraZeneca Ireland Limited, dated September 30, 2024 (Voyager Therapeutics, Inc., Filed With SEC on November 12, 2024)
First Amendment to Option and License Agreement, by and between Registrant and Novartis Pharma AG, dated September 3, 2024 (Voyager Therapeutics, Inc., Filed With SEC on November 12, 2024)
Amended and Restated License Agreement by and between Registrant and Paragon Therapeutics, Inc. dated as of September 20, 2024 (MIRAGEN THERAPEUTICS, INC., Filed With SEC on November 12, 2024)
License Agreement between the Company and Genentech, Inc., dated August 2, 202 (SANGAMO THERAPEUTICS, INC, Filed With SEC on November 12, 2024)
Sixth Amendment to License Agreement by and between the Company and President and Fellows of Harvard College, dated as of August 28, 2024 (Sana Biotechnology, Inc., Filed With SEC on November 8, 2024)
Amendment No. 2 to Amended and Restated License Agreement by and between the Company and the University of Rochester, dated as of May 30, 2024 (Sana Biotechnology, Inc., Filed With SEC on November 8, 2024)
License Agreement dated September 11, 2024, by and between the Registrant and Princeton 202 Associates Limited Partnership (Y-mAbs Therapeutics, Inc., Filed With SEC on November 8, 2024)
Patent License Agreement by and between the Company and Intract Pharma Limited dated September 11, 2024 (Hillstream BioPharma Inc., Filed With SEC on November 7, 2024)
Amendment #1 to License Agreement, dated August 30, 2024, by and among Akebia Therapeutics, Inc., Keryx Biopharmaceuticals, Inc. and Averoa SAS (Akebia Therapeutics, Inc., Filed With SEC on November 7, 2024)
License Agreement, entered into on October 29, 2024 and effective October 23, 2024, by and between Y-mAbs Therapeutics, Inc. and Nobelpharma Co., Ltd (Y-mAbs Therapeutics, Inc., Filed With SEC on November 4, 2024)
License Agreement between (Vir Biotechnology, Inc., Filed With SEC on November 4, 2024)
Option and License Agreement by and between IDEAYA Biosciences, Inc. and Biocytogen Pharmaceuticals (Beijing) Co., Ltd., dated July 30, 2024 (IDEAYA Biosciences, Inc., Filed With SEC on November 4, 2024)
Exclusive License Agreement by and between Day One Biopharmaceuticals, Inc. and Ipsen Pharma SAS dated July 23, 2024 (Day One Biopharmaceuticals Holding Co LLC, Filed With SEC on October 30, 2024)
License Agreement between Alexion and Monopar dated October 23, 2024 (Monopar Therapeutics, Filed With SEC on October 24, 2024)
Patent & Technology License Agreement, dated as of October 22, 2024, by and between Regulus Therapeutics Inc. and The Board of Regents of The University of Texas System, an agency... (Regulus Therapeutics Inc., Filed With SEC on October 24, 2024)
Amended and Restated Cell Line License Agreement, dated October 14, 2024, by and between the Company and WuXi Biologics (Hong Kong) Limited (Aeglea BioTherapeutics, Inc., Filed With SEC on October 15, 2024)
IL-23 (SPY003) License Agreement, dated October 11, 2024, by and between the Company and Paragon Therapeutics, Inc (Aeglea BioTherapeutics, Inc., Filed With SEC on October 15, 2024)
License Agreement, dated October 8, 2024, between Sonnet BioTherapeutics, Inc., Sonnet BioTherapeutics CH SA and Alkem Laboratories Limited (Chanticleer Holdings, Inc., Filed With SEC on October 9, 2024)
License Agreement between BioAtla, Inc. and Context Therapeutics Inc., dated as of September 23, 2024 (BioAtla, Inc., Filed With SEC on September 23, 2024)
Amendment No. 4 to Patent and Know-How License Agreement No. 07554F33, dated December 16, 2015, by and between the Registrant (formerly known as Genetix, Inc.) and INSERM-TRANSFERT (bluebird bio, Inc., Filed With SEC on September 13, 2024)
Amendment No. 3 to Patent and Know-How License Agreement No. 07554F33, dated October 29, 2014, by and between the Registrant (formerly known as Genetix, Inc.) and INSERM-TRANSFERT (bluebird bio, Inc., Filed With SEC on September 13, 2024)
Sixth Amendment to Exclusive License Agreement (Allarity Therapeutics, Inc., Filed With SEC on August 21, 2024)
Amended and Restated Exclusive Patent License Agreement with the Regents of the University of Minnesota, dated May 13, 2024 (GT Biopharma, Inc., Filed With SEC on August 14, 2024)
License and Technology Agreement, dated April 23, 2024, by and between the Registrant and Janssen Pharmaceuticals, Inc (Cidara Therapeutics, Inc., Filed With SEC on August 13, 2024)
License Agreement, dated May 14, 2024, by and between Medshine Discovery Inc., and Erasca, Inc (Erasca, Inc., Filed With SEC on August 12, 2024)
License Agreement, dated May 15, 2024, by and between Guangzhou Joyo Pharmatech Co., Ltd., and Erasca, Inc (Erasca, Inc., Filed With SEC on August 12, 2024)
Patent License Agreement, dated August 6, 2024, by and between Ainos, Inc. and Taiwan Carbon Nano Technology Corporation (AMARILLO BIOSCIENCES INC, Filed With SEC on August 9, 2024)